EKOS Corporation, a BTG International group company

📍 London, United Kingdom👥 74 employees💰 Last funded Jan 2008
EKOS Corporation, a BTG International group company, pioneered the development and clinical application of ultrasound infusion technologies in medicine. It introduced its first system for the treatment of vascular thrombosis (blood clots) in 2005. Since its beginning, EKOS has had one goal: develop life-enhancing and lifesaving treatments for blood clots that occur in arteries and veins. Our endovascular therapies improve patient outcomes, lower risks and improve treatment predictability.3,16,18 Today, interventional radiologists, cardiologists, vascular and cardiothoracic surgeons at leading institutions around the world use the EKOS EkoSonic® Endovascular System to provide faster, safer and more complete dissolution of thrombus.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in EKOS Corporation, a BTG International group company?
EKOS Corporation, a BTG International group company has 1 investors on record on gritt.io.
When did EKOS Corporation, a BTG International group company last raise funding?
The most recent investment in EKOS Corporation, a BTG International group company recorded on gritt.io was in January 2008.
What industry is EKOS Corporation, a BTG International group company in?
EKOS Corporation, a BTG International group company operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is EKOS Corporation, a BTG International group company based?
EKOS Corporation, a BTG International group company is headquartered in London, United Kingdom.